Texas Retina Associates (TRA) - Arlington

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Macular degeneration2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Amgen1 trial
• Ocular Therapeutix, Inc.1 trial

Running trials

• Recruiting

  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  NCT07614776· Phase 3· Amgen· Source

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

  NCT06223958· Phase 3· Ocular Therapeutix, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting